Acute Coronary Syndrome Scope: Growth, Share, Value, Size, and Analysis " Revenue analysis of the Acute Coronary Syndrome Market reveals a positive trajectory, with a revenue forecast predicting continued growth in the coming years. AstraZeneca, Daiichi Sankyo company, Johnson & Johnson Service Inc., Amgen Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc, Sanofi, CSL Behring, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International...